Leading the way to safer medication
 Crosscheck  Recommender

ATC Group: A10AD05 Insulin aspart

Anatomical Therapeutic Chemical Classification System


Insulin aspart

Hierarchical Position

Active Ingredients

Chemical substance

The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Insulin aspart produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. Insulin aspart has a shorter duration of action compared to soluble human insulin after subcutaneous injection.